Review full pharmacy documentation and consult your provider
Lillys tirzepatide delivered up to 22.5% weight loss in adults with obesity or overweight in SURMOUNT-1
Is it cheating to use GLP-1s
They guide you through each step, ensuring your semaglutide prescription is covered by insurance, and manage the prior authorization process for you, allowing you to focus entirely on your health objectives
During the mean observation period of 3.3 years, semaglutide at 2.4 mg per week resulted in a mean weight loss of 9.39% from baseline and a 20% reduction in the risk of MACE (HR 0.80, 95% CI 0.720.90), especially a 28% reduction in the risk of myocardial infarction (HR 0.72, 95% CI 0.610.85), compared with that in the placebo group
It enables accurate reconstitution while supporting consistency across repeated use, making it a dependable choice for research environments